NFKB1 and osteosarcoma: Similar to the above conclusions, this research confirmed that ATS decreased the protein levels of TRAF6, and reduced the TRAF6/NF-κB activity in osteosarcoma cells, prompting that ATS might have a protective function in osteosarcoma through the inactivation of the TRAF6/NF-κB signalling pathway.